ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2025.
Read more at globenewswire.com
Stereotaxis Reports 2025 Third Quarter Financial Results
Provided By GlobeNewswire - Last update: Nov 11, 2025
Article Mentions:
NYSEARCA:STXS (3/13/2026, 11:21:04 AM)
1.915
+0.04 (+1.86%)
Find more stocks in the Stock Screener
STXS Latest News and Analysis
4 days ago - By: Chartmill
